Cargando…

N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats

BACKGROUND: Neonatal abstinence syndrome (NAS) is a significant problem. Opioid withdrawal induces oxidative stress and disrupts glutamate and glutathione homeostasis. We hypothesized that N-acetylcysteine (NAC) administered during acute opioid withdrawal in neonatal rats would decrease withdrawal b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Price, Moss, Hunter G., Brown, Truman R., Kalivas, Peter, Jenkins, Dorothea D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Basic Science Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326708/ https://www.ncbi.nlm.nih.gov/pubmed/31935745 http://dx.doi.org/10.1038/s41390-019-0728-6

Ejemplares similares

NAC and Vitamin D Restore CNS Glutathione in Endotoxin-Sensitized Neonatal Hypoxic-Ischemic Rats
por: Adams, Lauren E., et al.
Publicado: (2021)

NAC and Vitamin D Improve CNS and Plasma Oxidative Stress in Neonatal HIE and Are Associated with Favorable Long-Term Outcomes
por: Jenkins, Dorothea D, et al.
Publicado: (2021)

Identifying the translational complexity of magnetic resonance spectroscopy in neonates and infants
por: Moss, Hunter G., et al.
Publicado: (2019)

Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis
por: Jenkins, Dorothea D., et al.
Publicado: (2015)

Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome
por: Jenkins, Dorothea D., et al.
Publicado: (2021)

S-Nitroso-N-Acetylcysteine Ameliorates Ischemia-Reperfusion Injury In The Steatotic Liver
por: Andraus, Wellington, et al.
Publicado: (2010)

N-Acetylcysteine Reverses Cocaine Induced Metaplasticity
por: Moussawi, Khaled, et al.
Publicado: (2009)

N-acetylcysteine and glycyrrhizin combination: Benefit outcome in a murine model of acetaminophen-induced liver failure
por: Minsart, Charlotte, et al.
Publicado: (2020)

N-Acetylcysteine Ameliorates Gentamicin-Induced Nephrotoxicity by Enhancing Autophagy and Reducing Oxidative Damage in Miniature Pigs
por: Cui, Jing, et al.
Publicado: (2019)

Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)
por: Stevens, Sarah, et al.
Publicado: (2021)

Neonatal Gastric Lactobezoar: Management with N-Acetylcysteine
por: Bajorek, Sarah, et al.
Publicado: (2012)

A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
por: Chisamore, Brian, et al.
Publicado: (2016)

A Novel Strategy for Attenuating Opioid Withdrawal in Neonates
por: Santoro, Giovanni C, et al.
Publicado: (2016)

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Eudy‐Byrne, Rena, et al.
Publicado: (2021)

Addressing drivers of healthcare utilization for neonatal opioid withdrawal syndrome
por: Glait, Megan, et al.
Publicado: (2022)

Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns
por: Esposito, Daina B., et al.
Publicado: (2022)

Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome
por: Baldo, Brian A.
Publicado: (2022)

Corrigendum to: Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
Publicado: (2022)

Characterization of neonatal opioid withdrawal syndrome in Arizona from 2010-2017
por: Eaves, Emery R., et al.
Publicado: (2021)

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
por: Tobacyk, Julia, et al.
Publicado: (2023)

Is this ‘complicated’ opioid withdrawal?
por: Parkar, S.R., et al.
Publicado: (2006)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

The impact of opioid exposure during pregnancy on the human neonatal immune profile
por: Miller, Nicholas W., et al.
Publicado: (2022)

Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model
por: Safa, Alireza, et al.
Publicado: (2021)

Economic Evaluation of Interventions for Treatment of Neonatal Opioid Withdrawal Syndrome: A Review
por: Lee, Evelyn, et al.
Publicado: (2021)

Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments
por: Tang, Fei, et al.
Publicado: (2021)

Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome
por: MacMillan, Kathryn Dee L., et al.
Publicado: (2022)

Molecular and long-term behavioral consequences of neonatal opioid exposure and withdrawal in mice
por: Dunn, Amelia D., et al.
Publicado: (2023)

Procedural pain assessment in neonates at risk of neonatal opioid withdrawal syndrome: a scoping review protocol
por: Lavergne, Julianna, et al.
Publicado: (2023)

Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials
por: Alam, Danesh, et al.
Publicado: (2020)

Fentanyl withdrawal: Iatrogenic opioid withdrawal syndrome: case report
Publicado: (2022)

Prenatal Exposures Are Associated With Worse Neurodevelopmental Outcomes in Infants With Neonatal Opioid Withdrawal Syndrome
por: Benninger, Kristen L., et al.
Publicado: (2020)

Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop
por: Simon, Alan E., et al.
Publicado: (2021)

Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning
por: Manigault, Andrew W., et al.
Publicado: (2022)

Cerebellum Susceptibility to Neonatal Asphyxia: Possible Protective Effects of N-Acetylcysteine Amide
por: Benterud, T., et al.
Publicado: (2018)

Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol
por: Mills-Huffnagle, Sara, et al.
Publicado: (2023)

Tramadol for the Management of Opioid Withdrawal: A Systematic Review of Randomized Clinical Trials
por: Shah, Kaushal, et al.
Publicado: (2020)

Toxicity mitigation by N-acetylcysteine and synergistic toxic effect of nano and bulk ZnO to Panagrellus redivivus
por: Kiss, Lola Virág, et al.
Publicado: (2021)

Alleviating Symptoms of Withdrawal from an Opioid
por: Wakim, Judith H.
Publicado: (2012)

Nonpharmacological Modality of Treating Opioid Withdrawal
por: Nair, Abhijit S
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l767vvatam1f59cnb7i0p4mvg8